Φορτώνει......
Safety of Eluxadoline in Patients with Irritable Bowel Syndrome with Diarrhea
OBJECTIVES: Eluxadoline is a mixed μ-opioid receptor (OR) and κ-OR agonist and δ-OR antagonist, approved for the treatment of irritable bowel syndrome with diarrhea (IBS-D). This analysis evaluated the safety and tolerability of eluxadoline 75 and 100 mg twice daily (BID) in one Phase 2 (IBS-2001) a...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Am J Gastroenterol |
|---|---|
| Κύριοι συγγραφείς: | , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Nature Publishing Group
2017
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5318664/ https://ncbi.nlm.nih.gov/pubmed/27922029 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ajg.2016.542 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|